Bright Bulbs

Illumina tops Technology Review's list of smartest companies.

Like a Tennis Match

A researcher criticizes two network papers, and the authors of one respond in a heated back-and-forth exchange.

This Week in PNAS

In PNAS this week: gene co-expression-based classification scheme for gliomas, microbial community changes in response to bioremediation, and more.

Fraud and Retractions, But Still a Patent

Disgraced stem cell researcher Hwang Woo-Suk receives a patent for his disputed method for cloning human embryos and extracting stem cells from them.

Origins and Ethics

The sequencing of an ancient American boy highlights ethical considerations.

DNA of the Past

The Guardian profiles Svante Pääbo and the rise of the field of ancient genomics.

This Week in PLOS

In PLOS this week: gene alterations linked to breast cancer outcomes, synthetic association in prostate cancer risk, and more.

This Week in Science

In Science this week: cortical convolutions, sequencing single cells.

IOM Considers Companion Dx

Companion diagnostics co-development efforts offer great potential, but face a difficult environment.

Collins on Creative Minds

Francis Collins is championing pioneering researchers studying genetic variants.

Canada Research Fund

Canada has unveiled a long-term plan to pump $1.4B into a new research fund.

Bigger Consequences

Is it time to criminalize research fraud?

Accelerating Medicines

The NIH and industry-led AMP is a new model for using genomic data to develop drugs and diagnostics.